Jump Financial LLC Buys New Shares in Chemed Corporation $CHE

Key Points

• Jump Financial LLC has acquired 4,513 shares of Chemed Corporation ($CHE) valued at approximately $2.77 million during the first quarter.
• Chemed reported earnings of $4.27 per share, missing the consensus estimate of $6.02 by $1.75, with revenue of $618.80 million for the quarter.
• The company has announced an increase in its quarterly dividend to $0.60 per share, representing an annualized dividend of $2.40 and a yield of 0.5%.

Jump Financial LLC bought a new position in Chemed Corporation (NYSE:CHE - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,513 shares of the company's stock, valued at approximately $2,777,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CHE. GAMMA Investing LLC lifted its stake in shares of Chemed by 131,200.8% in the first quarter. GAMMA Investing LLC now owns 166,752 shares of the company's stock valued at $102,606,000 after purchasing an additional 166,625 shares during the period. Freestone Grove Partners LP acquired a new stake in shares of Chemed in the fourth quarter valued at about $61,664,000. Point72 Asset Management L.P. acquired a new stake in shares of Chemed in the fourth quarter valued at about $54,587,000. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Chemed by 249.3% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 130,037 shares of the company's stock valued at $80,015,000 after purchasing an additional 92,813 shares during the period. Finally, Citadel Advisors LLC lifted its stake in shares of Chemed by 197.4% in the fourth quarter. Citadel Advisors LLC now owns 77,143 shares of the company's stock valued at $40,870,000 after purchasing an additional 51,206 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Transactions at Chemed

In other news, EVP Nicholas Michael Westfall sold 10,012 shares of Chemed stock in a transaction dated Monday, August 4th. The shares were sold at an average price of $421.91, for a total transaction of $4,224,162.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director George J. Walsh III purchased 200 shares of the stock in a transaction dated Monday, August 4th. The shares were purchased at an average price of $417.10 per share, with a total value of $83,420.00. Following the completion of the acquisition, the director owned 3,523 shares of the company's stock, valued at approximately $1,469,443.30. This represents a 6.02% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 3.29% of the company's stock.

Analyst Ratings Changes

Several analysts recently commented on the stock. Oppenheimer reduced their price objective on shares of Chemed from $650.00 to $580.00 and set an "outperform" rating for the company in a research note on Thursday, July 31st. Royal Bank Of Canada reduced their price objective on shares of Chemed from $640.00 to $589.00 and set an "outperform" rating for the company in a research note on Thursday, July 31st. Bank of America dropped their target price on shares of Chemed from $708.00 to $650.00 and set a "buy" rating for the company in a report on Monday, June 30th. Jefferies Financial Group initiated coverage on shares of Chemed in a report on Friday, July 25th. They set a "hold" rating and a $500.00 target price for the company. Finally, Wall Street Zen downgraded shares of Chemed from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $579.75.

Chemed Trading Up 1.5%

Shares of NYSE CHE traded up $6.72 during midday trading on Friday, reaching $458.62. 154,376 shares of the stock were exchanged, compared to its average volume of 172,316. The company has a market capitalization of $6.68 billion, a P/E ratio of 23.58, a P/E/G ratio of 2.52 and a beta of 0.46. Chemed Corporation has a 52-week low of $408.42 and a 52-week high of $623.60. The stock has a 50 day moving average price of $463.24 and a 200-day moving average price of $537.34.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing analysts' consensus estimates of $6.02 by ($1.75). The firm had revenue of $618.80 million for the quarter, compared to analysts' expectations of $650.60 million. Chemed had a return on equity of 25.83% and a net margin of 11.56%.The business's quarterly revenue was up 3.8% compared to the same quarter last year. During the same quarter last year, the firm earned $5.47 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, analysts forecast that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. This is a boost from Chemed's previous quarterly dividend of $0.50. The ex-dividend date was Monday, August 11th. Chemed's payout ratio is presently 12.34%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.